Project 2: Genes required for dendritic cell responses to pathogens and T cells
Project 2: Genes required for dendritic cell responses to pathogens and T cells
批准号:
10207350
负责人:
Nir Hacohen
金额:
$69.08万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2017
资助国家:
美国
项目状态:
已结题
起止时间:
2017-07-05 至 2023-06-30
关键词:
AcuteAddressAnimalsAntigen PresentationAntigensAttentionBacteriaBindingBiological AssayBone MarrowCD14 AntigenCD14 geneCD4 Positive T LymphocytesCRISPR libraryCRISPR screenCRISPR/Cas technologyCandidate Disease GeneCaspaseCell CommunicationCell physiologyCellsCellular biologyChromatinClustered Regularly Interspaced Short Palindromic RepeatsCollaborationsCommunicationCommunitiesCross PresentationDendritic CellsDendritic cell activationDetectionEndocytosisEndosomesEventGenesGeneticGenetic ScreeningGenetic TranscriptionGenomeGrantHelper-Inducer T-LymphocyteHistonesHost DefenseHumanImmuneImmune systemImmunityInfectionInflammationInflammatoryInformaticsIngestionInnate Immune ResponseInnate Immune SystemInterleukin-1Interleukin-2InvestigationKnowledgeLeadLipidsLipopolysaccharidesLymphocytic choriomeningitis virusLymphoidMammalian CellMeasurementMembrane ProteinsMessenger RNAMicrobeMonitorMusPathway interactionsPhosphorylationPhysiologyPlayProcessProtein BiosynthesisProteinsProteomeRNA SplicingRNA chemical synthesisRegulationReportingResearchResearch PersonnelResolutionRoleSeriesSignal PathwaySignal TransductionSignaling ProteinSiteSorting - Cell MovementSystemT-Cell ActivationT-LymphocyteTCF Transcription FactorTLR4 geneTransgenic MiceUbiquitinationWorkacute infectionadaptive immunitybasecandidate selectioncell typecytokinegene discoverygene functiongenetic regulatory proteingenome editinggenome-widein vivoinnovationknockout genemacrophagemicrobialnovelpathogenreceptorresponsesingle-cell RNA sequencingtranscription factor
中文摘要
点击翻译按钮获取中文摘要
英文摘要
The dendritic cells (DCs) of the mammalian innate immune system are responsible for detection of microbial
encounters and the initiation of inflammation and adaptive immunity. This central role of DCs in host physiology
has attracted much attention, and these cells are the subject of active investigation. Despite the appreciation of
the importance of DCs, there remain large and fundamental gaps in our knowledge of their mechanisms of
regulation. For instance, DCs encode several receptors that detect bacterial lipopolysaccharides (LPS), yet the
functions of only one (TLR4) have been examined extensively. Recent work by us and others have identified
the LPS receptors CD14 and caspase-11 as being capable of inducing novel signaling pathways that proceed
either upstream of TLR4 (CD14) or in parallel to TLR4 (caspase-11). The collective actions of CD14, TLR4 and
caspase-11 are important for DC activation and host defense, yet their mechanisms of action are poorly
defined. Thus, significant gaps in our knowledge exist to explain the earliest stages of DC interactions with
bacteria. We also lack an understanding of how DCs interact with T cells at later stages of infection, yet it is
clear that these interactions lead to profound changes in the activities of both cell types. Much of the research
into these interactions has focused on how DCs promote changes in T cell activities. In contrast, we have a
minimal understanding of how T cells influence the activity of DCs. In this application, we propose to fill these
gaps in our knowledge of DC biology through forward genetic screening for novel regulatory factors in mice.
This approach is facilitated by recent advances in genome editing provided by CRISPR-based technologies. A
pipeline of gene discovery will be generated through the use of established and emerging FACS-based
assays. These assays will be used in vivo and ex vivo to identify DCs that are deficient for regulators of DC
interactions with microbes or T cells. All screens will depend on significant interactions between the
informatics, mouse perturbation and CRISPR library Cores associated with this U19 application. Subsequent
functional analysis of candidate regulatory proteins will be performed in collaboration with other investigators
on this grant. The cumulative result of these efforts will be a series of novel gene sets that should define
pathways and processes that explain numerous aspects of DC biology as they relate to host defense.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Development of methods for highly multiplexed quantification of cancer proteomes using large-scale nanobody libraries
-
批准号:10714023
-
项目类别:
-
资助金额:$22.16万
-
财政年份:2023
-
负责人:Nir Hacohen
-
依托单位:
Factors regulating strength and duration of STING signaling
-
批准号:10677771
-
项目类别:
-
资助金额:$42.36万
-
财政年份:2021
-
负责人:Nir Hacohen
-
依托单位:
Factors regulating strength and duration of STING signaling
-
批准号:10367563
-
项目类别:
-
资助金额:$42.36万
-
财政年份:2021
-
负责人:Nir Hacohen
-
依托单位:
Factors regulating strength and duration of STING signaling
-
批准号:10490901
-
项目类别:
-
资助金额:$42.36万
-
财政年份:2021
-
负责人:Nir Hacohen
-
依托单位:
Regulation, function and localization of monocytes in autoimmune tissues
-
批准号:10598099
-
项目类别:
-
资助金额:$53.05万
-
财政年份:2021
-
负责人:Nir Hacohen
-
依托单位:
Regulation, function and localization of monocytes in autoimmune tissues
-
批准号:10088789
-
项目类别:
-
资助金额:$57.02万
-
财政年份:2021
-
负责人:Nir Hacohen
-
依托单位:
Regulation, function and localization of monocytes in autoimmune tissues
-
批准号:10427146
-
项目类别:
-
资助金额:$49.84万
-
财政年份:2021
-
负责人:Nir Hacohen
-
依托单位:
PREcision Medicine through IntErrogation of Rna in the kidnEy (PREMIERE)
-
批准号:10242728
-
项目类别:
-
资助金额:$56.09万
-
财政年份:2017
-
负责人:Nir Hacohen
-
依托单位:
PREcision Medicine through IntErrogation of Rna in the kidnEy (PREMIERE)
-
批准号:9910974
-
项目类别:
-
资助金额:$46.09万
-
财政年份:2017
-
负责人:Nir Hacohen
-
依托单位:
PREcision Medicine through IntErrogation of Rna in the kidnEy (PREMIERE)
-
批准号:10703510
-
项目类别:
-
资助金额:$62.74万
-
财政年份:2017
-
负责人:Nir Hacohen
-
依托单位:
PREcision Medicine through IntErrogation of Rna in the kidnEy (PREMIERE)
-
批准号:10513837
-
项目类别:
-
资助金额:$65.54万
-
财政年份:2017
-
负责人:Nir Hacohen
-
依托单位:
(PQ3) The role of damaged DNA in inter-individual variation of tumor immunity
-
批准号:9172929
-
项目类别:
-
资助金额:$51.82万
-
财政年份:2016
-
负责人:Nir Hacohen
-
依托单位:
(PQ3) The role of damaged DNA in inter-individual variation of tumor immunity
-
批准号:9750638
-
项目类别:
-
资助金额:$50.26万
-
财政年份:2016
-
负责人:Nir Hacohen
-
依托单位:
(PQ3) The role of damaged DNA in inter-individual variation of tumor immunity
-
批准号:9338211
-
项目类别:
-
资助金额:$51.82万
-
财政年份:2016
-
负责人:Nir Hacohen
-
依托单位:
(PQ3) The role of damaged DNA in inter-individual variation of tumor immunity
-
批准号:9982214
-
项目类别:
-
资助金额:$51.82万
-
财政年份:2016
-
负责人:Nir Hacohen
-
依托单位:
Non-coding genetic variants that impact immune phenotypes and diseases
-
批准号:9052201
-
项目类别:
-
资助金额:$87.15万
-
财政年份:2015
-
负责人:Nir Hacohen
-
依托单位:
Non-coding genetic variants that impact immune phenotypes and diseases
-
批准号:9249624
-
项目类别:
-
资助金额:$87.03万
-
财政年份:2015
-
负责人:Nir Hacohen
-
依托单位:
Core D: Antigen Receptor Identification and Tracking Core
-
批准号:10425267
-
项目类别:
-
资助金额:$16.31万
-
财政年份:2009
-
负责人:Nir Hacohen
-
依托单位:
Core D: Antigen Receptor Identification and Tracking Core
-
批准号:10654772
-
项目类别:
-
资助金额:$14.82万
-
财政年份:2009
-
负责人:Nir Hacohen
-
依托单位:
Core D: Antigen Receptor Identification and Tracking Core
-
批准号:10180874
-
项目类别:
-
资助金额:$42.19万
-
财政年份:2009
-
负责人:Nir Hacohen
-
依托单位:
海外基金